IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Travere Therapeutics Inc

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Citigroup Inc
UNCHANGED
Shares53,000 from 53,000
Change0 (0%)
Value$101.3K (+$3.2K)
Filed 2026-11-04
Truist Financial Corp
UNCHANGED
Shares41,000 from 41,000
Change0 (0%)
Value$87.0K (+$21.7K)
Filed 2026-10-30
Tenor Capital Management Co., L.P.
N/A
Shares— from 49,733,000
Change-49,733,000 (-100%)
Value—
Linden Advisors LP
N/A
Shares— from 28,076,000
Change-28,076,000 (-100%)
Value—
Lazard Asset Management LLC
N/A
Shares— from 4,118,000
Change-4,118,000 (-100%)
Value—
Goldman Sachs Group Inc
N/A
Shares— from 1,773,000
Change-1,773,000 (-100%)
Value—
Morgan Stanley
N/A
Shares— from 1,558,000
Change-1,558,000 (-100%)
Value—
FMR LLC
N/A
Shares— from 1,462,000
Change-1,462,000 (-100%)
Value—
Kohlberg Kravis Roberts & Co. L.P.
N/A
Shares— from 382,000
Change-382,000 (-100%)
Value—
Royal Bank of Canada
N/A
Shares— from 326,000
Change-326,000 (-100%)
Value—
Advent Capital Management
N/A
Shares— from 216,000
Change-216,000 (-100%)
Value—
Status
Citigroup Inc
UNCHANGED53,00053,00000%$98.1K$101.3K+$3.2K2026-11-04
Truist Financial Corp
UNCHANGED41,00041,00000%$65.3K$87.0K+$21.7K2026-10-30
Tenor Capital Management Co., L.P.
N/A—49,733,000-49,733,000-100%$92.6M———
Linden Advisors LP
N/A—28,076,000-28,076,000-100%$51.9M———
Lazard Asset Management LLC
N/A—4,118,000-4,118,000-100%$76.4K———
Goldman Sachs Group Inc
N/A—1,773,000-1,773,000-100%$3.3M———
Morgan Stanley
N/A—1,558,000-1,558,000-100%$2.9M———
FMR LLC
N/A—1,462,000-1,462,000-100%$2.7M———
Kohlberg Kravis Roberts & Co. L.P.
N/A—382,000-382,000-100%$709.0K———
Royal Bank of Canada
N/A—326,000-326,000-100%$603.0K———
Advent Capital Management
N/A—216,000-216,000-100%$402.5K———
Showing 11 of 11 institutions